| RD cases (N) |
13,654 |
4,214 |
23,113 |
| Mean age (years) |
59 |
72 |
51 |
| Female (%) |
41 |
42 |
43 |
| Observation time in years (median) |
5.5 |
5 |
5 |
| Observation time in years (IQR) |
4.96 |
3.64 |
5.89 |
| Cases with FQ class exposure, N(%) |
6,696 (49.04%) |
2,444 (58%) |
9,204 (39.82%) |
| Cases with FINTA exposure, N(%) |
271 (1.98%) |
34 (0.81%) |
469 (2.03%) |
| Cases with Amoxicillin exposure, N(%) |
4,271 (31.28%) |
1,468 (34.84%) |
7,716 (33.38%) |
| Cases with Azithromycin exposure, N(%) |
3,450 (25.27%) |
1,189 (28.22%) |
6,382 (27.61%) |
| Cases with Trimethoprim without Sulfamethoxazole exposure, N(%) |
1,112 (8.14%) |
371 (8.8%) |
2,220 (9.6%) |
| Cases with Trimethoprim with Sulfamethoxazole exposure, N(%) |
1,301 (9.53%) |
522 (12.39%) |
2,705 (11.7%) |
